Title: Novo Nordisk’s Strategy to Regain Dominance
Original: The Danish pharmaceutical leader is undergoing a major corporate transformation to reclaim its position at the forefront of the obesity treatment market.
Source: The Economist Generated at: 2025-12-15 21:28:07 UTC
Trump maintains audit immunity and appoints Pulte as Acting DNI.
Antonio Neri discusses his transition from Oracle to Apple, emphasizing the importance of design, user experience, and b...
Bloomberg Tech reports that Anthropic has officially filed for an IPO, submitting the necessary paperwork to the SEC.
An MSC ship was struck by two projectiles in an Iraqi port. Meanwhile, the U.S. has disabled five commercial vessels and...
Bloomberg Intelligence reports SpaceX is negotiating with bankers to reduce fees for its upcoming IPO. This move aims to...
Baillie Gifford’s Coutts and Burns discuss Europe and Japan’s projected double-digit earnings growth, noting sector-spec...
